These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4123332)

  • 1. Increase of T cells in Graves' disease.
    Aoki N; Wakisaka G; Nagata I
    Lancet; 1973 Jul; 2(7819):49-50. PubMed ID: 4123332
    [No Abstract]   [Full Text] [Related]  

  • 2. Increase of peripheral B lymphocytes in Graves' disease.
    Mori H; Amino N; Iwatani Y; Kabutomori O; Asari S; Motoi S; Miyai K; Kumahara Y
    Clin Exp Immunol; 1980 Oct; 42(1):33-40. PubMed ID: 6970099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [T- and B-lymphocytes in peripheral blood of children and adolescents with Graves' disease].
    Rybakowa M; Mytar B; Sołtysik-Wilk E; Pleti M; Mizerski J
    Endokrynol Pol; 1979; 30(4):361-6. PubMed ID: 315308
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of lymphocytes and thyrocytes in Graves' disease and nonautoimmune thyroid diseases in immunohistochemical and ultrastructural investigations.
    Ben-Skowronek I; Sierocinska-Sawa J; Szewczyk L; Korobowicz E
    Horm Res; 2009; 71(6):350-8. PubMed ID: 19506393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B- and T-lymphocytes in toxic diffuse goitre.
    Sköldstam L; Anderberg B; Norrby K
    Clin Exp Immunol; 1978 Mar; 31(3):524-5. PubMed ID: 350461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of T-cell immune abnormalities in peripheral blood lymphocytes in patients with Graves' disease or hypothyroidism.
    Mulaisho C; Abdou NI; Utiger RD
    J Clin Endocrinol Metab; 1975 Aug; 41(2):266-70. PubMed ID: 1080488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on T and B lymphocytes by the technique of immune and non-immune rosettes and by scanning electron microscopy (SEM) in Graves' disease and nontoxic nodular goiter.
    Necula M
    Endocrinologie; 1983; 21(4):261-5. PubMed ID: 6607508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune reactions in patients with Graves' disease.
    Bonnyns M; Cano P; Osterland CK; McKenzie JM
    Am J Med; 1978 Dec; 65(6):971-7. PubMed ID: 311156
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune mechanisms in Graves' disease.
    Burman KD; Baker JR
    Endocr Rev; 1985; 6(2):183-232. PubMed ID: 2988930
    [No Abstract]   [Full Text] [Related]  

  • 10. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis.
    Chan JY; Walfish PG
    Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
    Karlsson FA; Tötterman TH
    Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspects concerning the lymphocytic nonimmune and immune rosettes in Graves' disease and thyroiditis.
    Milcu SM; Necula M
    Endocrinologie; 1978; 16(1):51-4. PubMed ID: 305607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graves' disease: in situ localization of lymphoid T cell subpopulations.
    Bene MC; Derennes V; Faure G; Thomas JL; Duheille J; Leclere J
    Clin Exp Immunol; 1983 May; 52(2):311-6. PubMed ID: 6345038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: T-cell rosettes in thyrotoxic Graves's disease.
    Wara DW; Reiter EO; Ammann AJ; Kaplan SL
    N Engl J Med; 1973 Nov; 289(21):1145-6. PubMed ID: 4543183
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of peripheral T lymphocyte subpopulations in Graves' disease.
    Okabe N; Inoue K; Mori R
    J Clin Lab Immunol; 1983 Feb; 10(2):91-5. PubMed ID: 6221106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood T and B lymphocytes, in vitro stimulation with phytohemagglutinin, and sensitization with 2,4-dinitrochlorobenzene in Grave's disease.
    Maciel RM; Miki SS; Nicolau W; Mendes NF
    J Clin Endocrinol Metab; 1976 Mar; 42(3):583-7. PubMed ID: 767355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No major monoclonal lymphocyte population in the thyroid of patients with Graves' disease: study of gene rearrangement by restriction fragment length polymorphism and polymerase chain reaction.
    Petit-Simon C; Semana G; Quillivic F; Fauchet R; Genetet B; Allannic H
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1460-4. PubMed ID: 1350589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of IL-10 and IL-12 in CD40 and interleukin 4-activated mononuclear cells from patients with Graves' disease.
    Itoh M; Uchimura K; Makino M; Kobayashi T; Hayashi R; Nagata M; Kakizawa H; Fujiwara K; Nagasaka A
    Cytokine; 2000 Jun; 12(6):688-93. PubMed ID: 10843746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral thymus-dependent (T) lymphocytes in Graves's disease and Hashimoto's thyroiditis.
    Farid NR; Munro RE; Row VV; Volpé R
    N Engl J Med; 1973 Jun; 288(25):1313-7. PubMed ID: 4122370
    [No Abstract]   [Full Text] [Related]  

  • 20. Ia+ T cells in new onset Graves' disease.
    Jackson RA; Haynes BF; Burch WM; Shimizu K; Bowring MA; Eisenbarth GS
    J Clin Endocrinol Metab; 1984 Aug; 59(2):187-90. PubMed ID: 6610685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.